Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults

Clinical trial NCT06665828 · COMPLETED

Trial details

NCT number: NCT06665828
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2025-03-04
Primary completion: 2026-01-29
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.